Tumor-bearing mice with depleted CD8 T cells failed to respond to the combination therapy, with tumor growth (Fig. 2a) and survival rate (Fig. 2b) similar to vehicle-treated tumor-bearing mice. Here, CD8A is linked to neoplasm.